Powered by

Casma Therapeutics Receives Grant from Michael J. Fox Foundation to Support Parkinson's Drug Development

May 29, 2019 - Business Wire

Casma Therapeutics, Inc. , a biotechnology company harnessing the process of autophagy to design powerful new medicines, today announced receipt of a Therapeutic Pipeline Program research grant from The Michael J. Fox Foundation for Parkinson's Research (MJFF) to support development of a novel class of drugs to treat Parkinson's disease.

The $370,000 grant will advance Casma's research into drugs that activate the calcium channel TRPML1 to promote the cellular process of autophagy to clear...